# Multimodal Management of Facial Acne Scarring Using Energy-Based Devices and Injectable Therapies: A Case Report

**Authors:** Luis L Velázquez Arenas, Sarahi Garay Enriquez, Daniela Gómez

PMC · DOI: 10.7759/cureus.102151 · 2026-01-23

## TL;DR

A 35-year-old man with facial acne scars improved through a combination of laser treatments, injectables, and radiofrequency, showing effective scar management.

## Contribution

The paper presents a novel multimodal treatment approach combining energy-based devices and injectables for atrophic acne scarring.

## Key findings

- The patient showed progressive improvement in scar appearance and skin texture.
- The treatment approach was well-tolerated with no adverse events reported.

## Abstract

Acne vulgaris is a highly prevalent chronic inflammatory disorder that frequently results in permanent scarring, with atrophic scars representing the predominant type. The management of atrophic acne scarring is challenging due to variability in scar morphology, depth of dermal involvement, and patient-specific factors, often necessitating individualized and multimodal treatment strategies. We report the case of a 35-year-old male with facial atrophic acne scars treated using a combination of picosecond laser therapy, erbium:YAG laser resurfacing, injectable poly-L-lactic acid, hyaluronic acid filler, and microneedling radiofrequency over a structured treatment course. The patient demonstrated progressive improvement in scar appearance and skin texture, with good tolerability and no reported adverse events throughout follow-up. This case highlights the clinical application of a multimodal approach that integrates energy-based devices and injectable therapies to address multiple structural components of atrophic acne scarring.

## Linked entities

- **Diseases:** acne vulgaris (MONDO:0011438)

## Full-text entities

- **Diseases:** Acne vulgaris (MESH:D000152), collagen loss (MESH:D003095), acne scarring (MESH:D002921), skin pigmentation (MESH:D010859), atrophic (MESH:D020966), atrophy (MESH:D001284), pain (MESH:D010146), PIH (MESH:D017495), inflammatory (MESH:D007249)
- **Chemicals:** poly-L-lactic acid (MESH:C033616), Erbium (MESH:D004871), CO2 (MESH:D002245), isotretinoin (MESH:D015474), Er:YAG (-), HA (MESH:D006820), Sculptra (MESH:C482305)
- **Species:** Homo sapiens (human, species) [taxon 9606], Cutibacterium acnes (species) [taxon 1747]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12925485/full.md

---
Source: https://tomesphere.com/paper/PMC12925485